Authors:
Lumachi, F
Ermani, M
Basso, S
Zucchetta, P
Borsato, N
Favia, G
Citation: F. Lumachi et al., Localization of parathyroid tumours in the minimally invasive era: which technique should be chosen? Population-based analysis of 253 patients undergoing parathyroidectomy and factors affecting parathyroid gland detection, ENDOCR-R CA, 8(1), 2001, pp. 63-69
Authors:
Brandes, AA
Ermani, M
Basso, U
Amista, P
Berti, F
Scienza, R
Rotilio, A
Pinna, G
Gardiman, M
Monfardini, S
Citation: Aa. Brandes et al., Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: A phase II study, ANN ONCOL, 12(2), 2001, pp. 255-257
Authors:
Lumachi, F
Brandes, AA
Ermani, M
Bruno, G
Boccagni, P
Citation: F. Lumachi et al., Sensitivity of serum tumor markers CEA and CA 15-3 in breast cancer recurrences and correlation with different prognostic factors, ANTICANC R, 20(6C), 2000, pp. 4751-4755
Authors:
De Bona, M
Ponton, P
Ermani, M
Iemmolo, RM
Feltrin, A
Boccagni, P
Gerunda, G
Naccarato, R
Rupolo, G
Burra, P
Citation: M. De Bona et al., The impact of liver disease and medical complications on quality of life and psychological distress before and after liver transplantation, J HEPATOL, 33(4), 2000, pp. 609-615
Citation: F. Sartoretto et M. Ermani, Automatic detection of epileptiform activity by single-level wavelet analysis, CLIN NEU, 110(2), 1999, pp. 239-249
Authors:
Brandes, AA
Ermani, M
Turazzi, S
Scelzi, E
Berti, F
Amista, P
Rotilio, A
Licata, C
Fiorentino, MV
Citation: Aa. Brandes et al., Procarbazine and high-dose tamoxifen as a second-line regimen in recurrenthigh-grade gliomas: A phase II study, J CL ONCOL, 17(2), 1999, pp. 645-650